Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avadel Pharmaceuticals plc

9.72
+0.28002.97%
Post-market: 9.70-0.0200-0.21%16:53 EDT
Volume:738.47K
Turnover:7.19M
Market Cap:940.30M
PE:-35.47
High:9.86
Open:9.51
Low:9.50
Close:9.44
Loading ...

Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court Injunction

THOMSON REUTERS
·
07 May

Avadel Pharmaceuticals PLC expected to post a loss of 7 cents a share - Earnings Preview

Reuters
·
05 May

BRIEF-Avadel Pharmaceuticals To Provide A Corporate Update

Reuters
·
30 Apr

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7

THOMSON REUTERS
·
30 Apr

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7

GlobeNewswire
·
30 Apr

UBS Adjusts Avadel Pharmaceuticals Price Target to $12 From $14, Maintains Buy Rating

MT Newswires Live
·
28 Apr

Avadel, nference announce publication of data on sodium oxybate

TIPRANKS
·
17 Apr

Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience

GlobeNewswire
·
17 Apr

Loss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Set To Breakeven

Simply Wall St.
·
13 Apr

BRIEF-Avadel Announces Grant Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
11 Apr

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
11 Apr

Avadel Pharmaceuticals Price Target Maintained With a $19.00/Share by Needham

Dow Jones
·
09 Apr

Avadel Pharmaceuticals Projects 'Sustainable' Positive Cash Flow in 2025

MT Newswires Live
·
09 Apr

Avadel expects to generate sustainable positive cash flow in 2025

TIPRANKS
·
09 Apr

Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference

THOMSON REUTERS
·
09 Apr

Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference

GlobeNewswire
·
09 Apr

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

GlobeNewswire
·
05 Mar

Deutsche Bank Adjusts Avadel Pharmaceuticals Price Target to $13 From $12, Maintains Buy Rating

MT Newswires Live
·
04 Mar

Avadel Pharmaceuticals Plc : Deutsche Bank Raises Target Price to $13 From $12

THOMSON REUTERS
·
04 Mar

Avadel Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
04 Mar